144 related articles for article (PubMed ID: 20500515)
1. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis.
Sun H; Qiao Y; Zhang X; Xu L; Jia X; Sun D; Shen C; Liu A; Zhao Y; Jin Y; Yu Y; Bai J; Fu S
Cancer Sci; 2010 Aug; 101(8):1777-82. PubMed ID: 20500515
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies.
Ma Q; Zhao Y; Wang S; Zhang X; Zhang J; Du M; Li L; Zhang Y
Tumour Biol; 2014 Feb; 35(2):1473-80. PubMed ID: 24085356
[TBL] [Abstract][Full Text] [Related]
3. DNA repair gene XRCC3 Thr241Met polymorphisms and lung cancer risk: a meta-analysis.
Bei L; Xiao-Dong T; Yu-Fang G; Jian-Ping S; Zhao-Yu Y
Bull Cancer; 2015 Apr; 102(4):332-9. PubMed ID: 25794597
[TBL] [Abstract][Full Text] [Related]
4. No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.
Xu YH; Gu LP; Sun YJ; Cheng BJ; Lu S
Tumour Biol; 2013 Apr; 34(2):865-74. PubMed ID: 23300009
[TBL] [Abstract][Full Text] [Related]
5. Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.
He XF; Wei W; Li JL; Shen XL; Ding DP; Wang SL; Liu ZZ; Qin JB; Wu LX; Xie DL
Gene; 2013 Jul; 523(1):10-9. PubMed ID: 23562721
[TBL] [Abstract][Full Text] [Related]
6. DNA repair gene XRCC3 polymorphisms and bladder cancer risk: a meta-analysis.
Peng Q; Mo C; Tang W; Chen Z; Li R; Zhai L; Yang S; Wu J; Sui J; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1933-44. PubMed ID: 24104500
[TBL] [Abstract][Full Text] [Related]
7. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls.
Namazi A; Abedinzadeh M; Nourbaksh P; Neamatzadeh H
Asian Pac J Cancer Prev; 2015; 16(6):2263-8. PubMed ID: 25824748
[TBL] [Abstract][Full Text] [Related]
8. XRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.
Qin XP; Zhou Y; Chen Y; Li NN; Wu XT
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):226-34. PubMed ID: 24315014
[TBL] [Abstract][Full Text] [Related]
9. Meta analysis of XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia.
Xing ZS; Zhu G; Yang YL; Feng GQ; Ding GC
Asian Pac J Trop Med; 2014 Jun; 7(6):483-7. PubMed ID: 25066399
[TBL] [Abstract][Full Text] [Related]
10. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.
Wang Z; Zhang W
Tumour Biol; 2013 Jun; 34(3):1421-9. PubMed ID: 23504553
[TBL] [Abstract][Full Text] [Related]
11. Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis.
Yan Y; Liang H; Li T; Guo S; Li M; Qin X; Li S
Leuk Lymphoma; 2014 Sep; 55(9):2130-4. PubMed ID: 24304418
[TBL] [Abstract][Full Text] [Related]
12. XRCC3 Thr241Met is associated with response to platinum-based chemotherapy but not survival in advanced non-small cell lung cancer.
Qiu M; Xu L; Yang X; Ding X; Hu J; Jiang F; Xu L; Yin R
PLoS One; 2013; 8(10):e77005. PubMed ID: 24116196
[TBL] [Abstract][Full Text] [Related]
13. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies.
Huang G; Cai S; Wang W; Zhang Q; Liu A
PLoS One; 2013; 8(8):e68457. PubMed ID: 23990873
[TBL] [Abstract][Full Text] [Related]
14. Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis.
Liu J; Zhou Z; Lai T; Yin J
Tumour Biol; 2014 Feb; 35(2):1083-7. PubMed ID: 24061639
[TBL] [Abstract][Full Text] [Related]
15. XRCC3 Thr241Met polymorphism and clinical outcomes of NSCLC patients receiving platinum-based chemotherapy: a systematic review and meta-analysis.
Shen XY; Lu FZ; Wu Y; Zhao LT; Lin ZF
PLoS One; 2013; 8(8):e69553. PubMed ID: 23940523
[TBL] [Abstract][Full Text] [Related]
16. Association between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies.
Chai F; Liang Y; Chen L; Zhang F; Jiang J
Med Sci Monit; 2015 Oct; 21():3231-40. PubMed ID: 26498491
[TBL] [Abstract][Full Text] [Related]
17. XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis.
Li F; Li C; Jiang Z; Ma N; Gao X
Urology; 2011 Feb; 77(2):511.e1-5. PubMed ID: 20947146
[TBL] [Abstract][Full Text] [Related]
18. The XRCC3 Thr241Met polymorphism influences glioma risk - a meta-analysis.
Jiang J; Quan XF; Zhang L; Wang YC
Asian Pac J Cancer Prev; 2013; 14(5):3169-73. PubMed ID: 23803098
[TBL] [Abstract][Full Text] [Related]
19. Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis.
Zhang W; Yan B; Jiang L
Tumour Biol; 2013 Dec; 34(6):3989-93. PubMed ID: 23990458
[TBL] [Abstract][Full Text] [Related]
20. Association between the XRCC3 Thr241Met Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis.
Sahami-Fard MH; Mousa Mayali AR; Tajehmiri A
Asian Pac J Cancer Prev; 2016 Oct; 17(10):4599-4608. PubMed ID: 27892671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
